We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Issues Update on Additional Philips Respironics Ventilator Recall
FDA Issues Update on Additional Philips Respironics Ventilator Recall
The FDA has issued on update on Philips Respironics’ Dec. 21 recall of certain models of its Trilogy Evo ventilators, deeming it a Class 1 recall because of the risk of serious injury or death.